GLP-1 agonist tirzepatide and oral contraceptives The UKs MHRA recently issued guidance reminding patients using the GLP-1 agonist tirzepatide, who are also on oral contraceptives, that a barrier form of contraception should also be used
The stem cell organisation, and the proliferative and gene expression profile of Barretts epithelium, replicates pyloric-type gastric glands
Should your insurance deny coverage, you have the right to appeal the decision
Visit Tonums research hub for clinical summaries and study links to better understand oral options versus injectables
Recent studies show their effectiveness: patients have seen average weight loss of 10-20%, compared to only 2-4% with diet and exercise alone
GHK-Cus established wound healing benefits support faster recovery from such interventions while promoting optimal scarring outcomes